Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MLTX
MLTX logo

MLTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MLTX News

Rothschild & Co Upgrades MoonLake to Buy on Approval Path Clarity

5d agoseekingalpha

Cormorant Asset Management Increases Stake in MoonLake Immunotherapeutics

Mar 17 2026Fool

Significant Milestones in Biotech Sector This Week

Feb 27 2026NASDAQ.COM

MoonLake Immunotherapeutics Receives Upgraded Rating

Feb 23 2026Yahoo Finance

Vanda Pharmaceuticals Shares Surge 33% in Pre-Market Trading

Feb 23 2026Benzinga

Trump Announces Global Tariff Increase to 15%

Feb 23 2026stocktwits

MoonLake's S-OLARIS Trial Data Shows Positive Results

Feb 23 2026stocktwits

MoonLake's S-OLARIS Trial Results Show Significant Efficacy for Sonelokimab

Feb 22 2026Newsfilter

MLTX Events

No data

No data

MLTX Monitor News

MoonLake Immunotherapeutics Seeks BLA for Sonelokimab

Jan 09 2026

MoonLake Immunotherapeutics surges amid sector rotation

Jan 08 2026

MLTX.O Hits 20-Day High Amid Class Action Concerns

Nov 18 2025

MLTX Earnings Analysis

No Data

No Data

People Also Watch